Loading viewer...
investor_presentation
Format: PDF investor_presentation
Alinma's first quarter 2022 investor presentation covering financial performance, strategic updates, and market outlook. The presentation includes historical financial analysis, segmental performance review, and forward guidance across the company's digital, fast, and convenient service offerings.
investor_presentation
48 Pages
investor_presentation
23 Pages
Regeneron Pharmaceuticals, Inc.